TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
about
Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future ResearchReciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosisTGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunitiesRedox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expressionTGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansionElevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) miceHDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate.Serotonin receptors and heart valve disease--it was meant 2B.Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts.TGFβ-induced deptor suppression recruits mTORC1 and not mTORC2 to enhance collagen I (α2) gene expression.AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: implications for a Smad-3-dependent mechanismTransforming growth factor β integrates Smad 3 to mechanistic target of rapamycin complexes to arrest deptor abundance for glomerular mesangial cell hypertrophy.PAI-1 secretion of endometrial and endometriotic cells is Smad2/3- and ERK1/2-dependent and influences cell adhesionNSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.PAI-1 in tissue fibrosis.TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.Loss of heparin-binding protein prevents necrotizing glomerulonephritis: first clues hint at plasminogen activator inhibitor-1.Distinct signaling pathways activated by "extracellular" and "intracellular" serotonin in heart valve development and disease.Cellular functions regulated by phosphorylation of EGFR on Tyr845.Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.Src is a major signaling component for CTGF induction by TGF-beta1 in osteoblasts.PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report.PAI-1: An Integrator of Cell Signaling and Migration.TGF-β1-Induced Expression of the Anti-Apoptotic PAI-1 Protein Requires EGFR Signaling.Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interactionInhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice.TGF-beta1-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy.Differential requirement for MEK/ERK and SMAD signaling in PAI-1 and CTGF expression in response to microtubule disruption.Cerebrovascular Remodeling and Neuroinflammation is a Late Effect of Radiation-Induced Brain Injury in Non-Human Primates.NADPH Oxidase 4 Mediates TGFβ1-induced CCN2 in Gingival Fibroblasts.Transforming growth factor-β enhances Rho-kinase activity and contraction in airway smooth muscle via the nucleotide exchange factor ARHGEF1.Integration of Canonical and Noncanonical Pathways in TLR4 Signaling: Complex Regulation of the Wound Repair Program.Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process.TGR5 suppresses high glucose-induced upregulation of fibronectin and transforming growth factor-β1 in rat glomerular mesangial cells by inhibiting RhoA/ROCK signaling.Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.Deregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression.
P2860
Q26771727-BE0F62D8-6266-4221-8E3F-D8F72381C1CDQ26779846-1A99A325-F578-45C5-9886-23A8CB5DB1ABQ27022062-18BA30E4-B437-4D98-A2FB-55BC4A9960DAQ28512285-BA7ED747-E03F-490C-B08D-EFCAB5BD0C67Q28975741-1FC9365C-FF00-44E4-BCFC-9369D7E09CBCQ33590493-B48762C7-CD94-43D1-9811-B6C462F3CEBEQ34053101-3FDF0C91-AD4B-4047-8B44-BA200C8AEC67Q34173511-A3B8DCA3-FB90-4DBC-BE17-A7693B13D3FEQ34339468-B2BB2759-66FA-43C4-8290-1D3EAAA4B6A4Q35354812-CDD2C661-3A11-4DEB-A5AF-4E0D3DD94C6CQ36339405-4D6E083A-9029-431A-9184-756E2F499F1BQ36685205-6606B681-BEA7-4D76-9033-1D8521C9F14EQ36964196-55DCE5C0-D242-4C1C-AC17-546A229873D2Q37687793-2DC30BC8-E4EA-4916-801C-7FFD487A15E9Q37861626-21BB302F-F73A-415C-8E98-4873BBBB7029Q37884486-A50D5280-C830-4E94-B1E3-290FFB9B6D36Q38094620-42027C6D-8B16-43E2-804D-EF028929735BQ38100690-6E39C3F6-42AD-477A-9EEB-C42B52A3BAB9Q38109021-97161715-06E0-4818-948B-7D35B015CE67Q39315148-C69C50AA-98C1-4C1A-BC5A-224C94BF9604Q39708889-48D998C5-3C1B-4A9D-8881-353970EAF89CQ39709591-C2641355-300A-4901-B484-6724810CD747Q40287159-39F869ED-20F7-413B-A15E-12292C894072Q41493665-B50B6543-7BCE-4347-95B7-6327FBE1B8D7Q41896599-E8303904-467D-4795-8E1A-E4EA54CD150AQ42083363-ECB7B127-0060-448E-AABF-7B0A82EABAEFQ42733192-B9505A14-EF2B-49B7-A1ED-278FC3D4D4A3Q42936581-AEA23EE4-105F-49EE-ADF6-9EC6FC93456BQ43146931-E9DE4C35-FE33-4CC2-930F-F046D620E7E1Q43149092-A600819A-9DDF-4F5C-BF58-96EF0AB15746Q45056870-D52FE9BE-4965-4DF6-9145-5E4D94FD4F76Q46745979-58E59F5C-86D6-4C60-A032-7665912E56D0Q47098024-DC08C65C-FD97-4C98-B36A-CB8D8CB1A662Q47167999-3BF5F91F-D650-4A14-B6AC-2A918CB566FFQ47282821-A72015C8-FF39-493C-8617-798DD6E8DA9CQ51226366-2F77A675-21D6-41C2-99F2-1E9087ACEC54Q54775294-CAF87AC0-E015-45AF-975F-A3F05813A1EBQ55453582-A54846CA-88ED-44BE-A3B6-C824E8A497A2
P2860
TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
TGF-beta1-induced plasminogen ...... (Y845) and Rho/ROCK signaling.
@ast
TGF-beta1-induced plasminogen ...... (Y845) and Rho/ROCK signaling.
@en
type
label
TGF-beta1-induced plasminogen ...... (Y845) and Rho/ROCK signaling.
@ast
TGF-beta1-induced plasminogen ...... (Y845) and Rho/ROCK signaling.
@en
prefLabel
TGF-beta1-induced plasminogen ...... (Y845) and Rho/ROCK signaling.
@ast
TGF-beta1-induced plasminogen ...... (Y845) and Rho/ROCK signaling.
@en
P2093
P2860
P1476
TGF-beta1-induced plasminogen ...... (Y845) and Rho/ROCK signaling.
@en
P2093
Craig E Higgins
Paul J Higgins
Rohan Samarakoon
Stephen P Higgins
P2860
P304
P356
10.1016/J.YJMCC.2007.12.006
P577
2008-01-03T00:00:00Z